Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

The EU Definition of Nanomaterials – Getting what you wished for?

Published: Tuesday, May 01, 2012
Last Updated: Tuesday, May 01, 2012
Bookmark and Share
NanoSight’s Jeremy Warren, CEO, offers the latest news and views on the EU definition on nanomaterials.

Since first citations of the term “Nanotechnology”, scientific, industrial, public and political stakeholders have called for a robust regulatory framework to address the potential toxicological concerns surrounding these exciting new materials.

It is the promise of novel and useful properties from nano sizes of familiar materials that prompts a reappraisal of our knowledge of their potential toxicology and environmental impact.   These are effectively new materials.  The argument goes that, without public and political confidence, this new science risks fear and distrust, rather than being embraced as providing a multitude of solutions to challenges in the fields green energy, world food production or pharmaceutical advancement, to name but a few.

In October 2011 the EU Commission published a recommended definition of Nanomaterials (1). This definition is not the complete framework, but it is a significant step towards it.  Observers of embryonic nanotechnology regulation recognised this definition as the missing jigsaw piece in planned legislation; witness the French government largely adopting the definition’s wording and getting draft legislation on compulsory labeling of Nanomaterials out for consultation in under three months. Meanwhile other stakeholders in fields including nanomaterial manufacture and workplace exposure, handling, labeling, transportation and environmental fate now find they have an authoritative definition to slot into nascent regulation.

The key points of the definition are these:

1)    It is a Nanomaterial if any of these three criteria are met:
a)    At least 50% of the particles by count have one dimension external between 1 and 100nm.
b)    The material has a surface area greater than 60m2/cm3.
c)    The substance appears on an “include” list that captures materials such as graphene, which would otherwise fall outside the definition.
2)    The definition includes naturally-occurring as well as manufactured and incidentally manufactured particles.
3)    There are no specific recommendations on characterisation methods to meet these specifications.
4)    The definition is a recommendation, not a regulation; however its provenance bestows authority.

Despite protracted and energetic attempts by SCENIHR (the Scientific Committee on Emerging and Newly Identified Health Risks, part of the Directorate General for Health and Consumers) to draw stakeholders into consultation, much of industry and the scientific community appear taken by surprise here.  One can sympathise with the compliance officers in, for example, tyre manufacture or cement production, which suddenly find themselves within the nanotechnology industry.

Sympathize one might, but now a period of reflection is required to understand the scientific logic that generated this definition.

Reading back through SCENIHR’s publication, “Scientific Basis for the Definition of the Term “Nanomaterial”, they describe in depth the reasoning behind the definition. SCENIHR exhaustively discuss the possible measures and their benefits, and make clear the large areas of ambiguity and difficulty in these judgments.  Then, with some moral courage, they draft this definition, and in so doing take a step forward in supplying the urgent need for regulation.

The 100nm upper limit is essentially historic, coming from original definitions in nanotechnology.  It was arbitrary then, and is so now, but it is a start point.  Given this definition is specific to regulation, these numbers have to be precise to be enforceable.   Specifying count rather than weight per cent recognises that chemical reactivity increases per mass dose for smaller particles.  Parameters more closely relating to potential toxicity are missing – these are likely to follow on from this initial size-based definition. Regarding the lack of recommended characterisation methodologies, one need look no further than diesel combustion emissions or the water industry for precedents, where regulatory need sets scientists a measurement challenge – and maybe that is the right way to drive development of practical measurement methodologies?

Let me clearly state my interest here – NanoSight’s NTA (Nanoparticle Tracking Analysis) is at least a partial solution to the nanoparticle counting requirement, and in combination with occasional electron  microscopy to inform the bottom end of the 1 – 100nm range, we have a unique and practical, readily-implementable solution.

As the dust settles following the initial publication, reflect on the significant positive drivers from industry in support of legislation; Big business surely seeks to see nanotechnology de-risked?  Potential adverse public reaction hangs over nanotechnology, limiting investment and curbing strategic intent.  More cynically perhaps, big business deals better with regulation than SMEs; here is a barrier to entry that will ultimately lead to profitability in this sector.

To conclude, we welcome this definition as a starting point to deliver regulation on potential toxicity.   There is much research work to be done, and having this definition, this building block in place, will surely enable government investment in research to go the next steps, from simple physical parameters to the far more complex challenges of bioavailability and bio interaction at the heart of toxicology.  If industry and regulators can get this right, then far from labeling “contains nanomaterial” being in the smallest permissible font, we might see “Contains Nano” in a bright splash of colour, implying progressiveness, advanced and useful technology,  and above all, trustworthiness.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

The Jagiellonian University Uses NTA to Characterize Catalytic Nanoparticles
NTA used in the Faculty of Chemistry for the characterization of catalytic materials in environmental applications.
Thursday, July 11, 2013
The Institute of Water Resources & Water Supply Implements NTA to Characterize Colloids in Water
Professor Mathias Ernst has adopted the use of NTA technique to provide new insights into water quality.
Wednesday, June 26, 2013
Caltech Uses NTA to Characterize New Therapeutic Nanoparticles
Caltech to study nanoparticle-based therapeutics for the treatment of dementia, Parkinson's and Alzheimer's diseases.
Wednesday, May 01, 2013
Method Development to Estimate the Purity of Vesicle Preparations
Nanoparticle tracking analysis is used to estimate the purity of vesicle preparations at the Cardiff University School of Medicine.
Thursday, February 28, 2013
Polymer Nanoparticles Used as Drug Carriers Characterized Using Nanoparticle Tracking Analysis
NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is used to help with the characterization of polymeric nanoparticles synthesized as drug carrier systems.
Tuesday, February 12, 2013
NanoSight Announce New Appointment
Leading UK scientist, Dr Andrew Shuttleworth, joins NanoSight board as Director of Diagnostic Sciences.
Tuesday, June 26, 2012
NanoSight to Receive Queen's Award for Enterprise
Company announced it has been selected to receive the Queen's Award for Enterprise in the category for International Trade 2012.
Wednesday, May 02, 2012
Duke University Uses NTA to Characterize "Nanoconstructs" for Biomedical Applications
NTA to characterize metal nanoparticle construct materials for use in biosensing, imaging and cancer therapy.
Friday, April 20, 2012
“Nanomaterials” Defined by European Commission
Watchers of European legislation will recognise this as a watershed and a major move which will have consequence outside Europe.
Thursday, December 15, 2011
NanoSight wins Technology World's 2011 Business Innovation Award
The technology manufacturers are winners of this year's Technology World's 2011 Business Innovation Award in the category of Energy & Environment after receiving a record number of entries surrounding their optical detection and real time analysis of sub-micron particles.
Tuesday, December 06, 2011
NanoSight Recognized as the UK's Fastest Growing Biotech Company
Company has been ranked Fast 50 in the Deloitte 2011 UK technology ranking.
Thursday, November 17, 2011
NanoSight Latest Interactive Webinar: September 22nd Subject: Exosome Characterization by Nanoparticle Analysis
Latest webinar aimed at those with a similar interest in the detection and speciation of exosomes and micro-vesicles.
Friday, September 09, 2011
Landmark Publication Reports Potential of Exosomes as Biomarkers for Early Disease Detection
NanoSight reports the new publication in one of the most cited peer reviewed journals in nanoscience and nanotechnology, NanoMedicine.
Thursday, July 07, 2011
NanoSight announces interactive webinar on January 27th on Exosome Characterization by Nanoparticle Tracking Analysis
NanoSight, world-leading manufacturers of unique nanoparticle characterization technology, will host an interactive webinar on the subject of exosome characterization by Nanoparticle Tracking Analysis.
Thursday, January 20, 2011
Scientific News
Genetic Defences of Bacteria Don’t Aid Antibiotic Resistance
Genetic responses to the stresses caused by antibiotics don’t help bacteria to evolve a resistance to the medications, according to a new study by Oxford University researchers.
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Snapshot Turns T Cell Immunology on its Head
New research may have implications for 1 diabetes sufferers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
Horse Illness Shares Signs of Human Disease
Horses with a rare nerve condition have similar signs of disease as people with conditions such as Alzheimer’s, a study has found.
How a Molecular Motor Untangles Protein
Diseases such as Alzheimer’s, Parkinson’s and prion diseases, all involve “tangled” proteins.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos